The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

U.S. Physical Therapy Inc

NYSE: USPH
Last

(U.S.) $42.39

Today's change+0.34 +0.81%
Updated February 27 4:02 PM EST. Delayed by at least 15 minutes.
 

U.S. Physical Therapy Inc

NYSE: USPH
Last

(U.S.) $42.39

Today's change+0.34 +0.81%
Updated February 27 4:02 PM EST. Delayed by at least 15 minutes.

U.S. Physical Therapy Inc Hits New 50-day High

U.S. Physical Therapy Inc closed up Friday by (U.S.)$0.34 or 0.81% to (U.S.)$42.39 and setting a new 50-day high. Over the last five days, shares have gained 3.52%, but are currently unchanged over the last year to date. Shares have outperformed the S&P 500 by 14.26% during the last year.

Key company metrics

  • Open(U.S.) $42.10
  • Previous close(U.S.) $42.05
  • High(U.S.) $43.58
  • Low(U.S.) $41.89
  • Bid / Ask-- / --
  • YTD % change+1.02%
  • Volume51,542
  • Average volume (10-day)39,943
  • Average volume (1-month)45,769
  • Average volume (3-month)49,497
  • 52-week range(U.S.) $29.56 to (U.S.) $44.00
  • Beta0.92
  • Trailing P/E27.66×
  • P/E 1 year forward24.94×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.48
  • Dividend yield1.13%
  • Trailing EPS(U.S.) $1.53
Updated February 27 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.84%

Based on its net profit margin of 9.84%, U.S. Physical Therapy Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.04%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue78787069
Total other revenue--------
Total revenue78787069
Gross profit19221716
Total cost of revenue59565352
Total operating expense66646059
Selling / general / administrative7877
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income1114109
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax111499
Income after tax7966
Income tax, total4433
Net income5634
Total adjustments to net income--------
Net income before extra. items5634
Minority interest-2-3-3-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5634
Inc. avail. to common incl. extra. items5634
Diluted net income5634
Dilution adjustment--------
Diluted weighted average shares12121212
Diluted EPS excluding extraordinary itemsvalue per share0.430.520.270.32
Dividends per sharevalue per share0.120.120.120.10
Diluted normalized EPSvalue per share0.420.520.270.33